Abstract
Senescence is a permanent growth arrest that restricts the lifespan of primary cells in culture, and represents an in vitro model for aging. Senescence functions as a tumor suppressor mechanism that can be induced independent of replicative crisis by diverse stress stimuli. RNase-L mediates antiproliferative activities and functions as a tumor suppressor in prostate cancer, therefore, we examined a role for RNase-L in cellular senescence and aging. Ectopic expression of RNase-L induced a senescent morphology, a decrease in DNA synthesis, an increase in senescence-associated β-galactosidase activity, and accelerated replicative senescence. In contrast, senescence was retarded in RNase-L-null fibroblasts compared with wild-type fibroblasts. Activation of endogenous RNase-L by 2-5A transfection induced distinct senescent and apoptotic responses in parental and Simian virus 40-transformed WI38 fibroblasts, respectively, demonstrating cell type specific differences in the antiproliferative response to RNase-L activation. Replicative senescence is a model for in vivo aging; therefore, genetic disruption of senescence effectors may impact lifespan. RNase-L−/− mice survived 31.7% (P<0.0001) longer than strain-matched RNase-L+/+ mice providing evidence for a physiological role for RNase-L in aging. These findings identify a novel role for RNase-L in senescence that may contribute to its tumor suppressive function and to the enhanced longevity of RNase-L−/− mice.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bisbal C, Martinand C, Silhol M, Lebleu B, Salehzada T . (1995). Cloning and characterization of a RNAse L inhibitor. A new component of the interferon-regulated 2-5A pathway. J Biol Chem 270: 13308–13317.
Bisbal C, Silhol M, Laubenthal H, Kaluza T, Carnac G, Milligan L et al. (2000). The 2′-5′ oligoadenylate/RNase L/RNase L inhibitor pathway regulates both MyoD mRNA stability and muscle cell differentiation. Mol Cell Biol 20: 4959–4969.
Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AH, Schlegelberger B et al. (2005). Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436: 660–665.
Campisi J . (2003). Cancer and ageing: rival demons? Nat Rev Cancer 3: 339–349.
Carpten J, Nupponen N, Isaacs S, Sood R, Robbins C, Xu J et al. (2002). Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet 2000 30: 181–184.
Casey G, Neville PJ, Plummer SJ, Xiang Y, Krumroy LM, Klein EA et al. (2002). RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases. Nat Genet 32: 581–583.
Castelli JC, Hassel BA, Wood KA, Li XL, Amemiya K, Dalakas MC et al. (1997). A study of the interferon antiviral mechanism: apoptosis activation by the 2-5A system. J Exp Med 186: 967–972.
Chase BI, Zhou Y, Xiang Y, Silverman RH, Zhou A . (2003). Proteasome-mediated degradation of RNase L in response to phorbol-12-myristate-13-acetate (PMA) treatment of mouse L929 cells. J Interferon Cytokine Res 23: 565–573.
Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M et al. (2005). Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436: 725–730.
Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ, Barradas M et al. (2005). Tumour biology: senescence in premalignant tumours. Nature 436: 642.
Diaz G, Rivas C, Esteban M . (1997). Activation of the IFN-inducible enzyme RNase L causes apoptosis of animal cells. Virology 236: 354–363.
Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C et al. (1995). A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92: 9363–9367.
Dong B, Silverman RH . (1995). 2-5A-dependent RNase molecules dimerize during activation by 2-5A. J Biol Chem 270: 4133–4137.
Floyd-Smith G, Denton JS . (1988). Age-dependent changes are observed in the levels of an enzyme mediator of interferon action: a (2′-5′)A(n)-dependent endoribonuclease. Proc Soc Exp Biol Med 189: 329–337.
Hardy K, Mansfield L, Mackay A, Benvenuti S, Ismail S, Arora P et al. (2005). Transcriptional networks and cellular senescence in human mammary fibroblasts. Mol Biol Cell 16: 943–953.
Hassel BA, Zhou A, Sotomayor C, Maran A, Silverman RH . (1993). A dominant negative mutant of 2-5A-dependent RNase suppresses antiproliferative and antiviral effects of interferon. EMBO J 12: 3297–3304.
Hayflick L . (1965). The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 37: 614–636.
Iordanov MS, Paranjape JM, Zhou A, Wong J, Williams BR, Meurs EF et al. (2000). Activation of p38 mitogen-activated protein kinase and c-Jun NH(2)-terminal kinase by double-stranded RNA and encephalomyocarditis virus: involvement of RNase L, protein kinase R, and alternative pathways. Mol Cell Biol 20: 617–627.
Kaplan EL MP . (1958). Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457–481.
Kubota K, Nakahara K, Ohtsuka T, Yoshida S, Kawaguchi J, Fujita Y et al. (2004). Identification of 2′-phosphodiesterase, which plays a role in the 2-5A system regulated by interferon. J Biol Chem 279: 37832–37841.
Kulaeva OI, Draghici S, Tang L, Kraniak JM, Land SJ, Tainsky MA . (2003). Epigenetic silencing of multiple interferon pathway genes after cellular immortalization. Oncogene 22: 4118–4127.
Leszczyniecka M, Su ZZ, Kang DC, Sarkar D, Fisher PB . (2003). Expression regulation and genomic organization of human polynucleotide phosphorylase, hPNPase(old-35), a Type I interferon inducible early response gene. Gene 316: 143–156.
Li G, Xiang Y, Sabapathy K, Silverman RH . (2004). An apoptotic signaling pathway in the interferon antiviral response mediated by RNase L and c-Jun NH2-terminal kinase. J Biol Chem 279: 1123–1131.
Malathi K, Paranjape JM, Bulanova E, Shim M, Guenther-Johnson JM, Faber PW et al. (2005). A transcriptional signaling pathway in the IFN system mediated by 2′-5′-oligoadenylate activation of RNase L. Proc Natl Acad Sci USA 102: 14533–14538.
Malathi K, Paranjape JM, Ganapathi R, Silverman RH . (2004). HPC1/RNASEL mediates apoptosis of prostate cancer cells treated with 2′,5′-oligoadenylates, topoisomerase I inhibitors, and tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res 64: 9144–9151.
Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, van der Horst CM et al. (2005). BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436: 720–724.
Mulcahy LS, Smith MR, Stacey DW . (1985). Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells. Nature 313: 241–243.
Quarrie JK, Riabowol KT . (2004). Murine models of life span extension. Sci Aging Knowledge Environ 31: re5.
Schmitt CA . (2003). Senescence, apoptosis and therapy – cutting the lifelines of cancer. Nat Rev Cancer 3: 286–295.
Shay JW, Roninson IB . (2004). Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 23: 2919–2933.
Shelton DN, Chang E, Whittier PS, Choi D, Funk WD . (1999). Microarray analysis of replicative senescence. Curr Biol 9: 939–945.
Shou J, Soriano R, Hayward SW, Cunha GR, Williams PM, Gao WQ . (2002). Expression profiling of a human cell line model of prostatic cancer reveals a direct involvement of interferon signaling in prostate tumor progression. Proc Natl Acad Sci USA 99: 2830–2835.
Silverman RH . (2003). Implications for RNase L in prostate cancer biology. Biochemistry 42: 1805–1812.
Smith MR, DeGudicibus SJ, Stacey DW . (1986). Requirement for c-ras proteins during viral oncogene transformation. Nature 320: 540–543.
Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD . (1998). How cells respond to interferons. Annu Rev Biochem 67: 227–264.
Tahara H, Kamada K, Sato E, Tsuyama N, Kim JK, Hara E et al. (1995). Increase in expression levels of interferon-inducible genes in senescent human diploid fibroblasts and in SV40-transformed human fibroblasts with extended lifespan. Oncogene 11: 1125–1132.
Untergasser G, Koch HB, Menssen A, Hermeking H . (2002). Characterization of epithelial senescence by serial analysis of gene expression: identification of genes potentially involved in prostate cancer. Cancer Res 62: 6255–6262.
White MK, Khalili K . (2004). Polyomaviruses and human cancer: molecular mechanisms underlying patterns of tumorigenesis. Virology 324: 1–16.
Xin H, Pereira-Smith OM, Choubey D . (2004). Role of IFI 16 in cellular senescence of human fibroblasts. Oncogene 23: 6209–6217.
Yoon IK, Kim HK, Kim YK, Song IH, Kim W, Kim S et al. (2004). Exploration of replicative senescence-associated genes in human dermal fibroblasts by cDNA microarray technology. Exp Gerontol 39: 1369–1378.
Zhou A, Paranjape J, Brown TL, Nie H, Naik S, Dong B et al. (1997). Interferon action and apoptosis are defective in mice devoid of 2′,5′-oligoadenylate-dependent RNase L. EMBO J 16: 6355–6363.
Acknowledgements
We thank Dennis Stacey, Cleveland Clinic Foundation, for performing the microinjection experiments. We thank Dr Paul Torrence, Northern Arizona State University, for providing 2-5A. This work was supported by Grant AG20355 from the NIA, NIH, to BAH, a Glenn/American Federation for Aging Research Scholarship to CSJ, and a Grant from NIH, NCI CA044059 to RHS.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc).
Supplementary information
Rights and permissions
About this article
Cite this article
Andersen, J., Li, X., Judge, C. et al. Role of 2-5A-dependent RNase-L in senescence and longevity. Oncogene 26, 3081–3088 (2007). https://doi.org/10.1038/sj.onc.1210111
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1210111
Keywords
This article is cited by
-
Occludin Regulates HIV-1 Infection by Modulation of the Interferon Stimulated OAS Gene Family
Molecular Neurobiology (2023)
-
The function of RNase L and its degradation mechanism in cardiac acute ischemic injury
Apoptosis (2020)
-
IFN-γ restores the impaired function of RNase L and induces mitochondria-mediated apoptosis in lung cancer
Cell Death & Disease (2019)
-
Human serum RNase-L level is inversely associated with metabolic syndrome and age
Cardiovascular Diabetology (2017)
-
Age-related methylation profiles of equine blood leukocytes in the RNASEL locus
Journal of Applied Genetics (2016)